menu search

APVO / Why Did Aptevo Therapeutics Stock Jump 25% Today?

Why Did Aptevo Therapeutics Stock Jump 25% Today?
Aptevo Therapeutics Inc (NASDAQ: APVO) shares are trading higher Thursday after the company reported 2021 financial results.  Aptevo said royalty revenue totaled $12.3 million in 2021, up from royalties of $4.3 million in 2020. Read More
Posted: Mar 24 2022, 14:59
Author Name: Benzinga
Views: 042243

APVO News  

Aptevo to Present at Bio-Europe Conference

By Accesswire
November 1, 2023

Aptevo to Present at Bio-Europe Conference

SEATTLE, WA / ACCESSWIRE / November 1, 2023 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing nov more_horizontal

7 Millionaire-Maker Penny Stocks to Buy Before the Window Closes

By InvestorPlace
July 30, 2023

7 Millionaire-Maker Penny Stocks to Buy Before the Window Closes

Millionaire-maker penny stocks, as you might guess from the title does not represent a universally accessible sector. While these ideas can possibly m more_horizontal

Why Did Aptevo Therapeutics Stock Jump 25% Today?

By Benzinga
March 24, 2022

Why Did Aptevo Therapeutics Stock Jump 25% Today?

Aptevo Therapeutics Inc (NASDAQ: APVO) shares are trading higher Thursday after the company reported 2021 financial results.  Aptevo said royalty r more_horizontal

Why Are Aptevo Therapeutics Shares Trading Higher Today?

By Benzinga
February 9, 2022

Why Are Aptevo Therapeutics Shares Trading Higher Today?

Aptevo Therapeutics Inc APVO earned a $10 million non-dilutive milestone payment related to 2021 sales of Ruxience, under the terms of its royalty more_horizontal

Why Are Aptevo Therapeutics Shares Trading Higher Today?

By Benzinga
February 9, 2022

Why Are Aptevo Therapeutics Shares Trading Higher Today?

Aptevo Therapeutics Inc APVO earned a $10 million non-dilutive milestone payment related to 2021 sales of Ruxience, under the terms of its royalty more_horizontal

Why Are Aptevo Therapeutics Shares Trading Higher Today?

By Benzinga
February 9, 2022

Why Are Aptevo Therapeutics Shares Trading Higher Today?

Aptevo Therapeutics Inc APVO earned a $10 million non-dilutive milestone payment related to 2021 sales of Ruxience, under the terms of its royalty more_horizontal


Search within

Pages Search Results: